China · Delayed Price · Currency is CNY Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 7.99 billion. The enterprise value is 4.78 billion.
| Market Cap | 7.99B |
| Enterprise Value | 4.78B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | May 15, 2026 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -3.51% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -3.51% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 3.71% |
| Float | 41.68M |
Valuation Ratios
The trailing PE ratio is 50.82.
| PE Ratio | 50.82 |
| Forward PE | n/a |
| PS Ratio | 10.98 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | 130.21 |
| P/OCF Ratio | 45.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.53, with an EV/FCF ratio of 77.93.
| EV / Earnings | 30.42 |
| EV / Sales | 6.57 |
| EV / EBITDA | 23.53 |
| EV / EBIT | 42.57 |
| EV / FCF | 77.93 |
Financial Position
The company has a current ratio of 26.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.66 |
| Quick Ratio | 25.86 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.76 |
| Interest Coverage | 36.39 |
Financial Efficiency
Return on equity (ROE) is 2.83% and return on invested capital (ROIC) is 4.12%.
| Return on Equity (ROE) | 2.83% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 4.12% |
| Return on Capital Employed (ROCE) | 2.07% |
| Weighted Average Cost of Capital (WACC) | 8.68% |
| Revenue Per Employee | 680,719 |
| Profits Per Employee | 147,097 |
| Employee Count | 1,069 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.72 |
Taxes
In the past 12 months, SHE:301047 has paid 43.24 million in taxes.
| Income Tax | 43.24M |
| Effective Tax Rate | 21.57% |
Stock Price Statistics
The stock price has increased by +1.19% in the last 52 weeks. The beta is 0.81, so SHE:301047's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +1.19% |
| 50-Day Moving Average | 70.71 |
| 200-Day Moving Average | 72.66 |
| Relative Strength Index (RSI) | 26.60 |
| Average Volume (20 Days) | 1,002,146 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 727.69 million and earned 157.25 million in profits. Earnings per share was 1.29.
| Revenue | 727.69M |
| Gross Profit | 532.39M |
| Operating Income | 112.34M |
| Pretax Income | 200.48M |
| Net Income | 157.25M |
| EBITDA | 177.39M |
| EBIT | 112.34M |
| Earnings Per Share (EPS) | 1.29 |
Balance Sheet
The company has 3.26 billion in cash and 46.53 million in debt, with a net cash position of 3.21 billion or 26.38 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 46.53M |
| Net Cash | 3.21B |
| Net Cash Per Share | 26.38 |
| Equity (Book Value) | 5.34B |
| Book Value Per Share | 43.89 |
| Working Capital | 3.42B |
Cash Flow
In the last 12 months, operating cash flow was 176.81 million and capital expenditures -115.44 million, giving a free cash flow of 61.38 million.
| Operating Cash Flow | 176.81M |
| Capital Expenditures | -115.44M |
| Depreciation & Amortization | 65.05M |
| Net Borrowing | -31.09M |
| Free Cash Flow | 61.38M |
| FCF Per Share | 0.50 |
Margins
Gross margin is 73.16%, with operating and profit margins of 15.44% and 21.61%.
| Gross Margin | 73.16% |
| Operating Margin | 15.44% |
| Pretax Margin | 27.55% |
| Profit Margin | 21.61% |
| EBITDA Margin | 24.38% |
| EBIT Margin | 15.44% |
| FCF Margin | 8.43% |
Dividends & Yields
This stock pays an annual dividend of 5.20, which amounts to a dividend yield of 8.16%.
| Dividend Per Share | 5.20 |
| Dividend Yield | 8.16% |
| Dividend Growth (YoY) | 420.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 386.77% |
| Buyback Yield | 3.51% |
| Shareholder Yield | 11.73% |
| Earnings Yield | 1.97% |
| FCF Yield | 0.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |